Arylsulfatase B-deficient mucopolysaccharidosis in rats.
about
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's diseaseAnti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VILong-term amelioration of feline Mucopolysaccharidosis VI after AAV-mediated liver gene transferSensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage diseaseInvolvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidosesDiagnostic and treatment strategies in mucopolysaccharidosis VI.Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8.Animal models for mucopolysaccharidosis disorders and their clinical relevance.Structural, compositional, and biomechanical alterations of the lumbar spine in rats with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VILysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.The up-regulation of endosomal-lysosomal components in amyloid beta-resistant cells.Lysosomal storage diseases of animals: an essay in comparative pathology.Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models.Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation.Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.
P2860
Q21091189-EA495334-7856-4547-863D-BA413A4C1F41Q28476636-815F2EAD-BD0B-4783-B86F-E02E15BED0C0Q30498316-A38FBD66-F879-4FAB-962A-B2FD759A59E1Q30563980-1BA05F78-818B-4643-B545-80C1A1981E52Q30583745-119BB6A7-D200-41E0-8E06-9B2B275FB6C0Q33591661-AD6DF7A3-FEF3-4B67-B89E-3E208CE8B52FQ36253221-0CEA434D-1B37-4F7B-BD52-EBF689E64DACQ36357390-EBF0450F-217A-4852-8FA5-187495C5CEB4Q36634890-2E49DDEA-7313-4822-986A-E7B74B74209EQ36772983-F4AC96F0-D859-4734-9275-DD58A6200E96Q36821152-34CCF311-2A5C-4A36-B799-5630D93F4A02Q37354249-FAD7A04A-A63E-4C20-A0EC-3A2EC9FE3F30Q37357839-145590A3-6B99-4E69-92E0-90177F493C52Q37363292-58BDF2E8-10BE-4C7A-A4E1-DBD248104037Q37396626-88C39624-6A80-467A-BAF8-975D6EEA535CQ38684097-2835800C-DA65-436D-9E94-FF9D204EEAD7Q38853824-B7DBF860-AE28-4450-B4C2-7541B521511BQ40926433-0D6AA24C-FFCA-4475-80C0-63153F8E8BE1Q41659843-7C042462-0466-4E06-A8F2-90435D8245D7Q42176026-5892FB28-AA81-4BBB-8217-458581B28965Q45299603-AEAB75DF-80B1-4452-B435-CB0CEB3E1DA3Q45858480-477194B5-DF16-4379-93B5-44995F50E665Q47705730-3BA985F6-FD86-4FBD-A600-F850281F3976
P2860
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
description
1993 nî lūn-bûn
@nan
1993 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մարտին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@ast
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@en
type
label
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@ast
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@en
prefLabel
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@ast
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@en
P2093
P2860
P356
P1476
Arylsulfatase B-deficient mucopolysaccharidosis in rats.
@en
P2093
P2860
P304
P356
10.1172/JCI116268
P407
P577
1993-03-01T00:00:00Z